Company
Melbourne, VIC
Every investor coverage indicates participated in a round Murdoch Children's Research Institute raised.
Companies Murdoch Children's Research Institute acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Professor Mimi Tang | Professor (former) | SmartCompany (Fri 26 Apr 2024), SmartCompany (Fri 19 Jan 2024), Startup Daily |
Stories naming Murdoch Children's Research Institute. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Rampersand's April newsletter: an essay on AI services startups, model releases from Anthropic and Meta, Firmus Technologies' $505 million raise, Dexibit's sale to accesso, plus portfolio jobs, events and market commentary.
Also Dealroom·Cut Through Venture·Startup Daily·SmartCompany·SmartCompany·Forbes Australia·Business News Australia·Forbes Australia·Forbes Australia·Mirage News
Roundup of January 2024 funding: Futurerent, Prota Therapeutics, National Renewable Network and Getmee together secured $94.5 million across debt, equity and a government grant, with investor details for each deal.
Prota Therapeutics, a Melbourne biotech, has secured $32 million in equity and debt ahead of a Phase 3 trial of its peanut allergy therapy, with Singapore's SPRIM Global Investments leading the round.
Also SmartCompany·SmartCompany·SmartCompany·Business News Australia·Forbes Australia
Zetaris has banked a $30 million raise at a valuation topping $110 million, with Exto Partners leading and several co-investors; the company earlier won Ingram Micro's 2019 Comet Competition, worth up to $1.5 million.
Also ARN (ARNnet)·ARN (ARNnet)
Zetaris, a Victorian analytics firm, received an investment and partnership from Ingram Micro after its Cloud Comet Competition, enabling global expansion, while Ingram Micro Australia appointed Trent Gomersall as cloud director.